SPIA
ORIC icon

Steward Partners Investment Advisory’s Oric Pharmaceuticals ORIC Stock Holding History

Steward Partners Investment Advisory’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34K Buy
3,143
+1,493
+90% +$13.5K ﹤0.01% 3163
2026
Q1 		$20.9K Buy
+1,650
New +$18.7K ﹤0.01% 3208

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Steward Partners Investment Advisory's ORIC Position: Q2 2026 in Review

Steward Partners Investment Advisory increased its Oric Pharmaceuticals (ORIC) stake by 90% in Q2 2026, buying an estimated $13.5K and bringing the position to 3,143 shares worth $34K. The position accounts for ﹤0.01% of the portfolio, ranked #3163.

Steward Partners Investment Advisory first reported a position in ORIC in Q1 2026 and has held it in 2 quarters since. 180 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • Steward Partners Investment Advisory held 3,143 shares of Oric Pharmaceuticals worth $34K as of Q2 2026.
  • Steward Partners Investment Advisory bought 1,493 Oric Pharmaceuticals shares in Q2 2026, an estimated $13.5K.
  • Oric Pharmaceuticals made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #3163 holding.
  • Steward Partners Investment Advisory first reported a position in Oric Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 180 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.